SCHEMBL7241022

SCHEMBL7241022

CC(=O)Nc1ccc(-c2c3nc(c(-c4ccncc4)c4ccc([nH]4)c(-c4ccncc4)c4nc(c(-c5ccncc5)c5ccc2[nH]5)C=C4)C=C3)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TOP1 P11387 4/20 0.58
▸ CYCS P99999 3/20 0.52
▸ KDM4E B2RXH2 2/20 0.51
▸ GAA P10253 2/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ ABCG2 Q9UNQ0 1/20 0.51
▸ ENPP2 Q13822 1/20 0.48
▸ TSHR P16473 1/20 0.46
▸ HTT P42858 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ TERT O14746 3/20 0.45
▸ BRAF P15056 1/20 0.44
▸ MAPK13 O15264 1/20 0.43
▸ MAPK12 P53778 1/20 0.43
▸ MAPK11 Q15759 1/20 0.43
▸ MAPK14 Q16539 1/20 0.43
▸ HDAC3 O15379 1/20 0.43
▸ HDAC1 Q13547 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8994447 0.93 TOP1 (0.60) TOP1CYCSKDM4EALDH1A1HPGD
SCHEMBL9910535 0.88 ABCG2 (0.55) TOP1CYCSKDM4EALDH1A1HPGD
SCHEMBL14077524 0.87 ABCG2 (0.54) TOP1CYCSKDM4EALDH1A1HPGD
SCHEMBL7239829 0.87 ALDH1A1 (0.54) TOP1CYCSKDM4EGAAALDH1A1
SCHEMBL7252275 0.83 TOP1 (0.55) TOP1CYCSGAAHTTSMN1; SMN2
SCHEMBL7265156 0.82 MTNR1A (0.53) TOP1CYCSKDM4EALDH1A1HPGD
SCHEMBL1974241 0.82 TOP1 (0.68) TOP1CYCSKDM4EGAAALDH1A1
SCHEMBL9287001 0.82 TOP1 (0.52) TOP1CYCSABCG2ENPP2TERT
SCHEMBL9287004 0.80 TOP1 (0.53) TOP1CYCSHPGDABCG2ENPP2
SCHEMBL30968084 0.80 TOP1 (0.84) TOP1CYCSABCG2ENPP2TERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030203888-A1 Chromophores WELLCOME TRUST LIMITED, THE (GB) 2003-10-30 — — US disclosed
US-20030105130-A1 Thiaporphyrin, selenaporphyrin, and carotenoid porphyrin compounds as c-myc and telomerase inhibitors NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-06-05 — — US disclosed
EP-1294726-A2 IMPROVEMENTS IN AND RELATING TO CHROMOPHORES Catalyst Biomedica Ltd (GB) 2003-03-26 — — EP disclosed
WO-2002000662-A1 IMPROVEMENTS IN AND RELATING TO CHROMOPHORES CATALYST BIOMEDICA LIMITED (GB) 2002-01-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203888-A1 Chromophores HCCS, PPOX, HMBS TOP1 1754/4885CYCS 115/4885KDM4E 4639/4885
US-20030105130-A1 Thiaporphyrin, selenaporphyrin, and carotenoid porphyrin compounds as c-myc and telomerase inhibitors MYCBP, MYC, TERF2IP TOP1 132/4885CYCS 805/4885KDM4E 3753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback